Ferring International Center SA - Company Profile
Powered by 
All the data and insights you need on Ferring International Center SA in one report.
$295
- Save hours of research time and resources with
our up-to-date Ferring International Center SA Strategy Report
- Understand Ferring International Center SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Ferring International Center SA Catalyst Calendar
Proactively evaluate Ferring International Center SA’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Ferring International Center SA Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 17 Nov 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 17 Nov 2019 | Drug Expiry (EU) | Ferring International Center SA | - | progesterone | Women's Health | Women Infertility | GD Estimates |
| 02 Nov 2019 | Phase II Trial Completion | Bay State Clinical Trials Inc; Ferring International Center SA; PMG Research Inc | - | desmopressin acetate ODT; FE-201836 | Genito Urinary System And Sex Hormones | Nocturia; Polyuria (Hyperuresis) | Clinical Trial Registry |
| 14 Oct 2019 | Phase II Trial Initiation | Ferring International Center SA; The University of Nottingham; University of Birmingham; University of Edinburgh | - | dichloroacetate | Central Nervous System; Women's Health | Endometriosis; Pain | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer